Gamida Cell Ltd. (GMDA) Announces Proposed Common Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall St futures decline as US-Iran escalation rattles sentiment
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 3% as fresh military strikes threaten Hormuz shipments
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- The real reason Meta shares are surging has nothing to do with its new AI model
Gamida Cell (GMDA) Prices $65 Million Public Offering of Ordinary Shares at $8/sh
December 17, 2020 9:46 AM ESTGamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the pricing of a follow-on public offering of 8,125,000 ordinary shares at a public offering price of $8.00 per share for aggregate gross proceeds of $65.0... More
Gamida Cell Ltd. (GMDA) PT Lowered to $17 at Oppenheimer
December 15, 2020 7:17 AM ESTOppenheimer analyst Mark Briedenbach lowered the price target on Gamida Cell Ltd. (NASDAQ: GMDA) to $17.00 (from $20.00) while maintaining a Outperform rating.... More
Gamida Cell Ltd. (GMDA) PT Lowered to $12 at RBC Capital
December 15, 2020 6:15 AM ESTRBC Capital analyst Gregory Renza lowered the price target on Gamida Cell Ltd. (NASDAQ: GMDA) to $12.00 (from $13.00) while maintaining a Outperform rating.... More
